Article
DREAMSPHEN: a randomised controlled study comparing dose reduction of antipsychotics vs maintenance treatment in schizophrenia spectrum disorder after stratification based on patients' psychotic phenotype - study protocol of a personalised medicine approach.
BMJ open - 12 Jun 2026
Berna Fabrice, Horowitz Mark Abbie, Javelot Hervé, Meyer Nicolas, Foucher Jack R
Abstract excerpt
INTRODUCTION: The DREAMSPHEN study (Dose REduction of Antipsychotics vs. Maintenance treatment in schizophrenia after Stratification based on psychotic PHENotype) aims to compare the benefits and risks of a hyperbolic tapering method for antipsychotics to the maintenance of antipsychotics in a sample of clinically stabilised patients with schizophrenia spectrum disorder. METHODS AND ANALYSIS: A sample of 288...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
